Saliva Test Device Market Report 2026

Saliva Test Device Market Overview

• Saliva Test Device market size has reached to $1.16 billion in 2025 • Expected to grow to $1.79 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Increasing Incidence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Demand For Rapid And Non-Invasive Diagnostics • Market Trend: Enhancing Reproductive Health Through AI-Driven Saliva-Based Diagnostic Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Saliva Test Device Market?

A saliva test device is a diagnostic tool used to detect specific substances or biomarkers in a person's saliva. It is non-invasive, user-friendly, and often delivers rapid results. The main purpose of this device is to diagnose conditions such as infections, drug use, hormone imbalances, and various diseases. These devices are widely used in medical, forensic, and at-home testing settings. The main types of saliva test devices are 5-panel saliva test kits, 6-panel saliva test kits, 10-panel saliva test kits, 12-panel saliva test kits, and others. The 5-panel saliva test kit is designed to detect five specific substances or biomarkers, typically used for routine drug or health screening. The different sample types used include saliva, blood, and urine, which are analyzed using various technologies such as immunoassay, polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and microarray. These technologies are applied across multiple areas, including workplace testing, criminal justice testing, and disease testing, with end users spanning hospitals, clinics, diagnostic laboratories, and home care settings.

What Is The Saliva Test Device Market Growth Forecast?

The saliva test device market size is expected to see strong growth in the next few years. It will grow to $1.79 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to integration of ai and ml in saliva diagnostics, expansion of home healthcare testing, increasing adoption of pcr-based saliva tests, rising demand in disease monitoring, technological innovations in multiplex testing panels. Major trends in the forecast period include non-invasive diagnostic methods, rapid at-home testing, multi-drug detection panels, personalized health monitoring, expansion of forensic applications.

Global Saliva Test Device Market Segmentation

1) By Type: 5-Panel Saliva Test Kits, 6-Panel Saliva Test Kits, 10-Panel Saliva Test Kits, 12-Panel Saliva Test Kits, Other Types 2) By Sample Type: Saliva, Saliva Swab Samples, Oral Fluid Samples 3) By Technology: Immunoassay, Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA) 4) By Application: Workplace Testing, Criminal Justice Testing, Disease Testing 5) By End-User: Hospitals, Clinics, Diagnostic Laboratories, Home Care Settings Subsegments: 1) By 5-Panel Saliva Test Kits: Tetrahydrocannabinol, Cocaine, Opiates 2) By 6-Panel Saliva Test Kits: Amphetamines, Phencyclidine, Benzodiazepines 3) By 10-Panel Saliva Test Kits: Barbiturates, 3,4-Methylenedioxymethamphetamine, Methadone 4) By 12-Panel Saliva Test Kits: Oxycodone, Synthetic Cannabinoids, Fentanyl Or Tramadol 5) By Other Types: Custom Panel Kits, Alcohol Detection Kits, Single-Drug Test Kits

What Is The Driver Of The Saliva Test Device Market?

The increasing incidence of infectious diseases is expected to propel the growth of the saliva test device market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The rising prevalence of infectious diseases is due to increasing travel, which facilitates the rapid spread of pathogens across borders. Saliva test devices help detect infectious diseases by offering non-invasive and easy sample collection, making them ideal for at-home and point-of-care testing. They reduce diagnostic time by providing quick and accurate results, improving early detection and disease management. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the increasing incidence of infectious diseases is driving the growth of the saliva test device industry.

Key Players In The Global Saliva Test Device Market

Major companies operating in the saliva test device market are Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, PerkinElmer Inc, Neogen Corporation, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Porex Corporation, Everlywell Inc, DNA Genotek Inc, Premier Biotech Inc, Oasis Diagnostics Corporation, Salimetrics LLC, Securetec Detektions Systeme AG, AccuBioTech Co Ltd, Abionic SA, MyLab Box Inc, Oranoxis Inc, Salignostics Ltd, SD Biosensor Ltd, iHealth Labs Inc, Access Bio Inc

Global Saliva Test Device Market Trends and Insights

Major companies operating in the saliva test device market are focusing on developing technologically advanced solutions, such as integrating artificial intelligence in saliva-based tests, to improve diagnostic accuracy, enable real-time analysis, and enhance user convenience. Integration of artificial intelligence in saliva-based tests refers to the use of artificial intelligence (AI) algorithms to analyze test data, detect patterns, and deliver faster, more accurate diagnostic results. For instance, in July 2024, Ovulio Corp., a US-based fertility company, launched a saliva-based AI fertility tracker. It offers women a convenient, non-invasive way to monitor ovulation and hormonal trends using saliva samples analyzed by artificial intelligence. Its purpose is to empower users with accurate, real-time fertility insights for family planning and reproductive health management.

What Are Latest Mergers And Acquisitions In The Saliva Test Device Market?

In December 2023, Molbio Diagnostics Pvt. Ltd., an India-based manufacturing company, partnered with Testi Technologies Oy to commercialize and distribute advanced saliva-based self-test kits globally. This partnership aims to enhance access to non-invasive, rapid diagnostic solutions and strengthen global point-of-care testing capabilities. Testi Technologies Oy is a Finland-based health tech company specializing in the development of innovative saliva test devices.

Regional Outlook

North America was the largest region in the saliva test device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Saliva Test Device Market?

The saliva test device market consists of revenues earned by entities by providing services such as saliva sample collection, diagnostic testing, result interpretation, remote health monitoring, and at-home testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The saliva test device market also includes sales of oral swab test kits, rapid saliva test devices, and saliva-based diagnostic tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.